Sialix Cancer Research

About:

Sialix Cancer Research is an institute that offers cancer antigen and cancer antibodies.

Top Investors: LaunchPad Venture, Desert Angels, Beacon Angels, Maine Angels, Mass Medical Angels

Description:

Sialix Cancer Research provides cancer susceptibility antibodies and cancer-associated nucleoprotein antibodies for breast cancer. They also offer laser-based photodynamic endoscopic diagnosis using 5-aminolevulinic acid for early gastric adenocarcinoma and gastric adenoma.

Total Funding Amount:

$1.2M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-07-31

Founders:

Number of Employees:

1-10

Last Funding Date:

2014-02-05

IPO Status:

Private

Industries: